Evidence map›Paper›PMID 25773887›Full record

ArticleJournal of lipid research2015

Salicylate improves macrophage cholesterol homeostasis via activation of Ampk.

Morgan D Fullerton, Rebecca J Ford, Chelsea P McGregor, Nicholas D LeBlond, Shayne A Snider, Stephanie A Stypa, Emily A Day, Šárka Lhoták, Jonathan D Schertzer, Richard C Austin and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Nutrients · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Morgan D FullertonDivisions of Endocrinology and Metabolism McMaster University, Hamilton, Canada Department of Medicine, and Departments of Biochemistry and Biomedical Sciences McMaster University, Hamilton, Canada Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.
Rebecca J FordDivisions of Endocrinology and Metabolism McMaster University, Hamilton, Canada.
Chelsea P McGregorDepartment of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.
Nicholas D LeBlondDepartment of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.
Shayne A SniderDepartment of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.
Stephanie A StypaDivisions of Endocrinology and Metabolism McMaster University, Hamilton, Canada.
Emily A DayDivisions of Endocrinology and Metabolism McMaster University, Hamilton, Canada.
Šárka LhotákHamilton Centre for Kidney Research, St. Joseph's Healthcare Hamilton, Hamilton, Canada Nephrology, McMaster University, Hamilton, Canada.
Jonathan D SchertzerDepartment of Medicine, and Departments of Biochemistry and Biomedical Sciences McMaster University, Hamilton, Canada Pediatrics, McMaster University, Hamilton, Canada.
Richard C AustinHamilton Centre for Kidney Research, St. Joseph's Healthcare Hamilton, Hamilton, Canada Nephrology, McMaster University, Hamilton, Canada.
Bruce E KempSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, Fitzroy, Australia.
Gregory R SteinbergDivisions of Endocrinology and Metabolism McMaster University, Hamilton, Canada Department of Medicine, and Departments of Biochemistry and Biomedical Sciences McMaster University, Hamilton, Canada.
McMaster University · CAUniversity of Ottawa · CASt. Joseph’s Healthcare Hamilton · CAUniversity of Melbourne · AU

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Atherosclerosis stems from imbalances in lipid metabolism and leads to maladaptive inflammatory responses. The AMP-activated protein kinase (Ampk) is a highly conserved serine/threonine kinase that regulates many aspects of lipid and energy metabolism, although its specific role in controlling macrophage cholesterol homeostasis remains unclear. We sought to address this question by testing the effects of direct Ampk activators in primary bone marrow-derived macrophages from Ampk β1-deficient (β1(-/-)) mice. Macrophages from Ampk β1(-/-) mice had enhanced lipogenic capacity and diminished cholesterol efflux, although cholesterol uptake was unaffected. Direct activation of Ampk β1 via salicylate (the unacetylated form of aspirin) or A-769662 (a small molecule activator), decreased the synthesis of FAs and sterols in WT but not Ampk β1(-/-) macrophages. In lipid-laden macrophages, Ampk activation decreased cholesterol content (foam cell formation) and increased cholesterol efflux to HDL and apoA-I, effects that occurred in an Ampk β1-dependent manner. Increased cholesterol efflux was also associated with increased gene expression of the ATP binding cassette transporters, Abcg1 and Abca1. Moreover, in vivo reverse cholesterol transport was suppressed in mice that received Ampk β1(-/-) macrophages compared with the WT control. Our data highlight the therapeutic potential of targeting macrophage Ampk with new or existing drugs for the possible reduction in foam cell formation during the early stages of atherosclerosis.

Indexed as

AMP-Activated Protein KinasesAnimalsApolipoprotein A-IAtherosclerosisCells, CulturedCholesterolCholesterol, HDLDrug Evaluation, PreclinicalEnzyme ActivationEnzyme ActivatorsFoam CellsHomeostasisLipogenesisMice, KnockoutSalicylic AcidAMP-Activated Protein KinasesApolipoprotein A-ICholesterolCholesterol, HDLEnzyme ActivatorsPrkab1 protein, mouseSalicylic Acidadenosine 5′-monophosphate-activated protein kinaseatherosclerosischolesterol effluxlipid homeostasisreverse cholesterol transport

Identifiers

PMID25773887
PMCPMC4409279
OpenAlexW2054880823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.